Memorial Sloan Kettering Cancer Center in New York City has appointed two oncology chiefs.

Separately, oncologist Thomas Weiner, a former employee, also faces a civil suit, which alleges he overbilled the government for cancer services and overprescribed medications, among other claims.

University of Michigan Health-West has named a new chief medical officer.  Dr. Clifford Cho was appointed CMO of University of Michigan Health-West in May 2024.

Celyad Oncology (Euronext: CYAD) (the “Company” or “Celyad”) is pleased to announce Matt Kane as its new Chief Executive Officer (CEO), effective as of October 1st, 2024. Matt Kane is a ...

The new executive director of New York Oncology Hematology is Allyson Letendre Petrone, the physician group announced Monday.

This report is a review of recent and emerging trends that promise to make radiation oncology for prostate cancer more ...

Simply sign up to the Pharmaceuticals sector myFT Digest -- delivered directly to your inbox. Pfizer’s oncology chief has warned that the Biden administration’s drug price reforms could hurt ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--TheRas, Inc. d/b/a BridgeBio Oncology Therapeutics (“BBOT” or the “Company”), a clinical-stage precision oncology company, has announced the appointment ...

Newly appointed CMO, Dr. Emmanuelle Dochy, and newly appointed CSO, Dr. Maurizio Ceppi, bring a strong track record of advancing cancer ...

L.C. proudly announces the appointment of Dr. Rico Buchli as Chief Scientist. In his new role, Dr. Buchli will ...

MONT-SAINT-GUIBERT, Belgium, September 16, 2024--(BUSINESS WIRE)--Regulatory News: Celyad Oncology (Euronext: CYAD) (the "Company" or "Celyad") is pleased to announce Matt Kane as its new Chief ...